Related Experiment Video
Updated: May 5, 2026
08:56
Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies
Published on: October 7, 2021
3.3K
Uncommon dyselectrolytemia complicating Guillain-Barré syndrome
Aralikatte Onkarappa Saroja1, Karkal Ravishankar Naik, Mallikarjun S Khanpet
1Department of Neurology, KLE University's Jawaharlal Nehru Medical College and KLES', Dr. Prabhakar Kore Hospital and MRC, Nehrunagar, Belgaum - 590 010, India.
Journal of Neurosciences in Rural Practice
|November 20, 2013
Summary
Guillain-Barré syndrome (GBS) can rarely occur with severe hypokalemia and hypomagnesemia, complicating diagnosis and treatment of acute flaccid quadriparesis. This case highlights the challenges in managing such complex electrolyte imbalances in GBS patients.
Area of Science:
- Neurology
- Internal Medicine
- Clinical Electrophysiology
Background:
- Guillain-Barré syndrome (GBS) and hypokalemic paralysis are distinct causes of acute flaccid quadriparesis.
- Differentiating these conditions is crucial as their treatments differ significantly.
Observation:
- This report details a rare case of a 41-year-old male presenting with acute flaccid quadriparesis.
- The patient exhibited simultaneous severe hypokalemia and hypomagnesemia alongside GBS.
Findings:
- The co-occurrence of GBS with severe hypokalemia and hypomagnesemia presented a significant diagnostic and therapeutic dilemma.
- Managing complex dyselectrolytemia in the context of GBS requires careful evaluation for underlying metabolic disturbances.
Implications:
- This case underscores the importance of considering and investigating complex electrolyte abnormalities in patients with GBS.
- Such evaluations are critical for appropriate management and to rule out associated inherited or metabolic conditions.
Related Concept Videos
01:15Myasthenia Gravis: Diagnostic Tests
3.3K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.3K
01:19Depolarizing Blockers: Pharmocokinetics
784
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
784
01:28Diphtheria
187
Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
187
01:20Myasthenia Gravis: Overview and Treatment
3.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.7K
01:22Myasthenia Gravis ll: Pathophysiology
69
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
69
01:28Depolarizing Blockers: Mechanism of Action
3.4K
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
3.4K